# MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

> **NCT06043232** · — · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Glioma

## Interventions

- **BIOLOGICAL:** DC vaccine

## Key facts

- **NCT ID:** NCT06043232
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043232, "MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06043232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*